FATE THERAPEUTICS INC's ticker is and the CUSIP is 31189P902. A total of 4 filers reported holding FATE THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $1 | 0.0% | 600 | +100.0% | 0.00% | – |
Q2 2023 | $1 | -85.7% | 300 | -76.9% | 0.00% | – |
Q1 2023 | $7 | -92.9% | 1,300 | -86.9% | 0.00% | – |
Q4 2022 | $99 | -99.9% | 9,900 | +54.7% | 0.00% | – |
Q3 2022 | $143,000 | +70.2% | 6,400 | +88.2% | 0.00% | – |
Q2 2022 | $84,000 | -69.0% | 3,400 | -51.4% | 0.00% | – |
Q1 2022 | $271,000 | +577.5% | 7,000 | +900.0% | 0.00% | – |
Q4 2021 | $40,000 | -90.1% | 700 | -83.7% | 0.00% | – |
Q3 2021 | $405,000 | +6.3% | 4,300 | -2.3% | 0.00% | – |
Q2 2021 | $381,000 | +21.7% | 4,400 | +11478.9% | 0.00% | -100.0% |
Q1 2021 | $313,000 | +19.0% | 38 | +31.0% | 0.00% | – |
Q4 2020 | $263,000 | +748.4% | 29 | +262.5% | 0.00% | – |
Q3 2020 | $31,000 | -97.2% | 8 | -97.6% | 0.00% | -100.0% |
Q2 2020 | $1,121,000 | -13.7% | 327 | -44.1% | 0.00% | 0.0% |
Q1 2020 | $1,299,000 | -13.1% | 585 | -23.4% | 0.00% | -33.3% |
Q4 2019 | $1,495,000 | +81.4% | 764 | +43.9% | 0.00% | +50.0% |
Q3 2019 | $824,000 | +132.1% | 531 | +203.4% | 0.00% | +100.0% |
Q2 2019 | $355,000 | +6.6% | 175 | -7.9% | 0.00% | 0.0% |
Q1 2019 | $333,000 | +24.3% | 190 | -9.1% | 0.00% | 0.0% |
Q4 2018 | $268,000 | +6.3% | 209 | +34.8% | 0.00% | 0.0% |
Q3 2018 | $252,000 | +28.6% | 155 | -10.4% | 0.00% | 0.0% |
Q2 2018 | $196,000 | +216.1% | 173 | +4.2% | 0.00% | -66.7% |
Q1 2018 | $62,000 | – | 166 | +3220.0% | 0.00% | – |
Q4 2017 | $0 | – | 5 | +150.0% | 0.00% | – |
Q3 2017 | $0 | – | 2 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
GROUP ONE TRADING, L.P. | 700 | $1,484 | 0.00% |
SIMPLEX TRADING, LLC | 600 | $1 | 0.00% |
CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |